GYPA and Obesity: Since PCSK9 has a variety of functions outside the liver, not all of which are fully understood, the EGFA-GPA mice reported here could serve as a model to systematically explore the function of circulatory PCSK9 in the pathogenesis of diabetes, inflammation, sepsis, viral infections, and especially, obesity.